mode of action of glp 1 agonists Glucagon-like peptide-1 Current Insights, Advantages and Challenges
Description
AstraZeneca, Novo Nordisk A/S, Eli Lilly and Company, Sanofi and Hypera S.A
Recent studies...
Discover Now!
Purpose Chronic kidney disease (CKD) is one of the most common complications of type 2 diabetes (T2D), and CKD-related disability and mortality are increasing despite the recent advances in diabetes management
This review delves into the physiological roles of GLP-1, exploring its impact on ...
GLP-1R agonists and perioperative outcomes 1
